| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C26H24FNO |
| Molar mass | 385.482 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
JWH-307 is ananalgesic drug used in scientific research, which acts as acannabinoid agonist at both theCB1 andCB2receptors. It is somewhat selective for the CB2 subtype, with aKi of 7.7 nM at CB1 vs 3.3 nM at CB2.[1] It was discovered by, and named after,John W. Huffman. JWH-307 was detected as an ingredient insynthetic cannabis smoking blends in 2012, initially in Germany.[2][3]
In the United States, CB1 receptor agonists of the 3-(1-naphthoyl)pyrrole class such as JWH-307 areSchedule I Controlled Substances.[4]
Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |